Movement Alert|Humana Intraday Rise 3.19% in Regular Trading, Jefferies Raises Price Target After Q3-Driven Estimate Revisions

Market Focus11-11

On November 11, Humana rose 3.19% in Regular Trading, trading at $436.06 per share, with turnover of $127 million.

The latest identifiable catalyst was a fresh analyst action: Jefferies raised its price target on Humana to $520 from $420, following a broader wave of forecast increases after the company’s recent third-quarter results.

Earlier, Humana reported a third-quarter adjusted loss of $0.70 per share on revenue of $41.16 billion, both better than consensus expectations for a $1.00 loss and $40.87 billion in revenue. The company also raised its adjusted EPS guidance for 2026 to at least $9.50 from at least $9.00, above the $9.16 consensus view. Additional post-results target increases included $526 from Piper Sandler and analyst forecasts rising into a $495 to $587 range, reinforcing a more constructive valuation backdrop for the managed-care insurer.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment